Experienced in Infantile Apnea

Dr. Sherry E. Courtney

Neonatology | Pediatrics
1 Childrens Way # 653, 
Little Rock, AR 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Infantile Apnea
1 Childrens Way # 653, 
Little Rock, AR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sherry Courtney is a Neonatologist and a Pediatrics provider in Little Rock, Arkansas. Dr. Courtney is rated as an Experienced provider by MediFind in the treatment of Infantile Apnea. Her top areas of expertise are Bronchopulmonary Dysplasia, Premature Infant, Infant Respiratory Distress Syndrome, and Cerebral Hypoxia. Dr. Courtney is currently accepting new patients.

Her clinical research consists of co-authoring 44 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Infantile Apnea.

Specialties
Neonatology
Pediatrics
Licenses
Pediatrics in NY
Languages Spoken
English
French
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO

Locations

1 Childrens Way # 653, Little Rock, AR 72202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
Enrollment Status: Recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drug: SHP607
Study Phase: Phase 2
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Other, Drug
Study Drug: Sildenafil
Study Phase: Phase 2
Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study
Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study
Enrollment Status: Terminated
Publish Date: March 05, 2024
Intervention Type: Drug
Study Drug: Remodulin
Study Phase: Phase 2
High-dose Erythropoietin for Asphyxia and Encephalopathy
High-dose Erythropoietin for Asphyxia and Encephalopathy
Enrollment Status: Completed
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Erythopoietin
Study Phase: Phase 3
Effect of Synchronized vs. Continuous High Flow Nasal Cannula Using Neurally Adjusted Ventilatory Assist on Work of Breathing in Infants With Bronchopulmonary Dysplasia
Effect of Synchronized vs. Continuous High Flow Nasal Cannula Using Neurally Adjusted Ventilatory Assist on Work of Breathing in Infants With Bronchopulmonary Dysplasia
Enrollment Status: Terminated
Publish Date: May 05, 2022
Intervention Type: Other
Study Phase: Not Applicable
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia
Enrollment Status: Completed
Publish Date: December 28, 2021
Intervention Type: Drug, Other
Study Drug: Furosemide
Study Phase: Phase 2
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess The Safety and Efficacy of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age With Respiratory Distress Syndrome
Enrollment Status: Completed
Publish Date: April 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Clinical Study to Evaluate the Safety and Effectiveness of the Infinity Acute Care System Workstation Neonatal Care Babylog VN500 Device in High Frequency Oscillatory Ventilation (HFOV) Mode in Very Low Birth Weight (VLBW) Neonates
A Clinical Study to Evaluate the Safety and Effectiveness of the Infinity Acute Care System Workstation Neonatal Care Babylog VN500 Device in High Frequency Oscillatory Ventilation (HFOV) Mode in Very Low Birth Weight (VLBW) Neonates
Enrollment Status: Unknown
Publish Date: September 19, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

44 Total Publications

Corrigendum to "Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial" J Pediatr. 2025 Apr 28;283:114629.
Corrigendum to "Furosemide Safety in Preterm Infants at Risk for Bronchopulmonary Dysplasia: A Randomized Clinical Trial" J Pediatr. 2025 Apr 28;283:114629.
Journal: The Journal of pediatrics
Published: August 15, 2025
Similar Doctors
Experienced in Infantile Apnea
Dr. David N. Matlock
Neonatology | Pediatrics
Experienced in Infantile Apnea
Dr. David N. Matlock
Neonatology | Pediatrics
1 Childrens Way, Slot 512-19a, 
Little Rock, AR 
 (0.1 miles away)
501-364-1874
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Matlock is a Neonatologist and a Pediatrics provider in Little Rock, Arkansas. Dr. Matlock is rated as an Experienced provider by MediFind in the treatment of Infantile Apnea. His top areas of expertise are Premature Infant, Bronchopulmonary Dysplasia, Infantile Apnea, and Infant Respiratory Distress Syndrome. Dr. Matlock is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Courtney's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile